These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33123960)

  • 1.
    Dao HH; Hlaing MZ; Ma Y; Surewicz K; Surewicz WK; Jaroniec CP
    Biomol NMR Assign; 2021 Apr; 15(1):45-51. PubMed ID: 33123960
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Theint T; Nadaud PS; Surewicz K; Surewicz WK; Jaroniec CP
    Biomol NMR Assign; 2017 Apr; 11(1):75-80. PubMed ID: 28004358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-solvent interfaces in human Y145Stop prion protein amyloid fibrils probed by paramagnetic solid-state NMR spectroscopy.
    Aucoin D; Xia Y; Theint T; Nadaud PS; Surewicz K; Surewicz WK; Jaroniec CP
    J Struct Biol; 2019 Apr; 206(1):36-42. PubMed ID: 29679649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid fibrils from the N-terminal prion protein fragment are infectious.
    Choi JK; Cali I; Surewicz K; Kong Q; Gambetti P; Surewicz WK
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13851-13856. PubMed ID: 27849581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural polymorphism in amyloids: new insights from studies with Y145Stop prion protein fibrils.
    Jones EM; Wu B; Surewicz K; Nadaud PS; Helmus JJ; Chen S; Jaroniec CP; Surewicz WK
    J Biol Chem; 2011 Dec; 286(49):42777-42784. PubMed ID: 22002245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular conformation and dynamics of the Y145Stop variant of human prion protein in amyloid fibrils.
    Helmus JJ; Surewicz K; Nadaud PS; Surewicz WK; Jaroniec CP
    Proc Natl Acad Sci U S A; 2008 Apr; 105(17):6284-9. PubMed ID: 18436646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermolecular alignment in Y145Stop human prion protein amyloid fibrils probed by solid-state NMR spectroscopy.
    Helmus JJ; Surewicz K; Apostol MI; Surewicz WK; Jaroniec CP
    J Am Chem Soc; 2011 Sep; 133(35):13934-7. PubMed ID: 21827207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational Dynamics in the Core of Human Y145Stop Prion Protein Amyloid Probed by Relaxation Dispersion NMR.
    Shannon MD; Theint T; Mukhopadhyay D; Surewicz K; Surewicz WK; Marion D; Schanda P; Jaroniec CP
    Chemphyschem; 2019 Jan; 20(2):311-317. PubMed ID: 30276945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117V.
    Tagliavini F; Lievens PM; Tranchant C; Warter JM; Mohr M; Giaccone G; Perini F; Rossi G; Salmona M; Piccardo P; Ghetti B; Beavis RC; Bugiani O; Frangione B; Prelli F
    J Biol Chem; 2001 Feb; 276(8):6009-15. PubMed ID: 11087738
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Zhang Q; Zhang H; Zheng F; Liu R; Liao X; Guo C; Lin D
    Biomol NMR Assign; 2021 Oct; 15(2):311-316. PubMed ID: 33871829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the Dynamically Disordered N-Terminal Tail Domain on the Amyloid Core Structure of Human Y145Stop Prion Protein Fibrils.
    Qi Z; Surewicz K; Surewicz WK; Jaroniec CP
    Front Mol Biosci; 2022; 9():841790. PubMed ID: 35237664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational flexibility of Y145Stop human prion protein amyloid fibrils probed by solid-state nuclear magnetic resonance spectroscopy.
    Helmus JJ; Surewicz K; Surewicz WK; Jaroniec CP
    J Am Chem Soc; 2010 Feb; 132(7):2393-403. PubMed ID: 20121096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of N-terminal familial mutations in prion protein fibrillization and prion amyloid propagation in vitro.
    Jones EM; Surewicz K; Surewicz WK
    J Biol Chem; 2006 Mar; 281(12):8190-6. PubMed ID: 16443601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregation Condition-Structure Relationship of Mouse Prion Protein Fibrils.
    Fridmanis J; Toleikis Z; Sneideris T; Ziaunys M; Bobrovs R; Smirnovas V; Jaudzems K
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Mechanism of Barriers to Interspecies Seeding Transmissibility of Full-Length Prion Protein Amyloid.
    Ma T; Deng J; Ma S; Zhao W; Chang Z; Yu K; Yang J
    Chembiochem; 2019 Nov; 20(21):2757-2766. PubMed ID: 31161647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide bond conformation in peptides and proteins probed by dipolar coupling-chemical shift tensor correlation solid-state NMR.
    Mukhopadhyay D; Gupta C; Theint T; Jaroniec CP
    J Magn Reson; 2018 Dec; 297():152-160. PubMed ID: 30396157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper binding alters the core structure of amyloid fibrils formed by Y145Stop human prion protein.
    Sridharan V; George T; Conroy DW; Shaffer Z; Surewicz WK; Jaroniec CP
    Phys Chem Chem Phys; 2024 Oct; 26(41):26489-26496. PubMed ID: 39392708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations.
    Piccardo P; Liepnieks JJ; William A; Dlouhy SR; Farlow MR; Young K; Nochlin D; Bird TD; Nixon RR; Ball MJ; DeCarli C; Bugiani O; Tagliavini F; Benson MD; Ghetti B
    Am J Pathol; 2001 Jun; 158(6):2201-7. PubMed ID: 11395398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of infectious, non-fibrillar and oligomeric prions from a genetic prion disease.
    Vanni I; Pirisinu L; Acevedo-Morantes C; Kamali-Jamil R; Rathod V; Di Bari MA; D'Agostino C; Marcon S; Esposito E; Riccardi G; Hornemann S; Senatore A; Aguzzi A; Agrimi U; Wille H; Nonno R
    Brain; 2020 May; 143(5):1512-1524. PubMed ID: 32303068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Description of the first Spanish case of Gerstmann-Sträussler-Scheinker disease with A117V variant: clinical, histopathological and biochemical characterization.
    Eraña H; San Millán B; Díaz-Domínguez CM; Charco JM; Rodríguez R; Viéitez I; Pereda A; Yañez R; Geijo M; Navarro C; Perez de Nanclares G; Teijeira S; Castilla J
    J Neurol; 2022 Aug; 269(8):4253-4263. PubMed ID: 35294616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.